{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T13:12:58Z","timestamp":1784380378469,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.cellsig.2025.111910","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T11:11:55Z","timestamp":1748430715000},"page":"111910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Tumor suppressor FBXO11 drives ubiquitin proteasomal degradation of KIF2C to limit ovarian cancer progression and is transcriptionally repressed by ZNF217"],"prefix":"10.1016","volume":"134","author":[{"given":"Qingqing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cellsig.2025.111910_bb0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.soncn.2019.02.001","article-title":"Ovarian cancer: an integrated review","volume":"35","author":"Stewart","year":"2019","journal-title":"Semin. Oncol. Nurs."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111910_bb0010","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1002\/ijc.30676","article-title":"International patterns and trends in ovarian cancer incidence, overall and by histologic subtype","volume":"140","author":"Coburn","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111910_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: a review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol. Med."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111910_bb0020","first-page":"1239","article-title":"Clinical and translational advances in ovarian cancer therapy","volume":"4","author":"Konstantinopoulos","year":"2023","journal-title":"Nat. Can."},{"key":"10.1016\/j.cellsig.2025.111910_bb0025","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/497429","article-title":"Treatment for recurrent ovarian cancer-at first relapse","volume":"2010","author":"Ushijima","year":"2010","journal-title":"J. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111910_bb0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13048-020-00705-9","article-title":"High preoperative serum sVCAM-1 concentration as a predictor of early ovarian cancer recurrence","volume":"13","author":"Jakimovska","year":"2020","journal-title":"J. Ovarian Res."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111910_bb0035","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrm1471","article-title":"The SCF ubiquitin ligase: insights into a molecular machine","volume":"5","author":"Cardozo","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111910_bb0040","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.7150\/thno.42735","article-title":"F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects","volume":"10","author":"Tekcham","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.cellsig.2025.111910_bb0045","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev-biochem-090120-013613","article-title":"Cullin-RING ubiquitin ligase regulatory circuits: a quarter century beyond the F-box hypothesis","volume":"90","author":"Harper","year":"2021","journal-title":"Annu. Rev. Biochem."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111910_bb0050","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1074\/jbc.M114.632125","article-title":"The oncogenic microRNA-21 inhibits the tumor suppressive activity of FBXO11 to promote tumorigenesis","volume":"290","author":"Yang","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111910_bb0055","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ccr.2014.07.022","article-title":"PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis","volume":"26","author":"Zheng","year":"2014","journal-title":"Cancer cell"},{"issue":"7379","key":"10.1016\/j.cellsig.2025.111910_bb0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature10688","article-title":"FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas","volume":"481","author":"Duan","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111910_bb0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.canlet.2015.03.037","article-title":"FBXO11 promotes ubiquitination of the snail family of transcription factors in cancer progression and epidermal development","volume":"362","author":"Jin","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2025.111910_bb0070","article-title":"Characterization of kinesin family member 2C as a proto-oncogene in cervical cancer","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cellsig.2025.111910_bb0075","doi-asserted-by":"crossref","first-page":"1434856","DOI":"10.1155\/2021\/1434856","article-title":"KIF2C is a novel prognostic biomarker and correlated with immune infiltration in endometrial cancer","volume":"2021","author":"An","year":"2021","journal-title":"Stem Cells Int."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111910_bb0080","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s12935-021-02235-w","article-title":"TBX15\/miR-152\/KIF2C pathway regulates breast cancer doxorubicin resistance via promoting PKM2 ubiquitination","volume":"21","author":"Jiang","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111910_bb0085","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.bjc.6603905","article-title":"Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancer","volume":"97","author":"Nakamura","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.cellsig.2025.111910_bb0090","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/sj.bjc.6604379","article-title":"Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer","volume":"98","author":"Ishikawa","year":"2008","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111910_bb0095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13048-021-00837-6","article-title":"Integrative analysis of key candidate genes and signaling pathways in ovarian cancer by bioinformatics","volume":"14","author":"Dong","year":"2021","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.cellsig.2025.111910_bb0100","article-title":"HitPredict version 4: comprehensive reliability scoring of physical protein-protein interactions from more than 100 species","volume":"Dec 26","author":"L\u00f3pez","year":"2015","journal-title":"Database (Oxford)"},{"issue":"11","key":"10.1016\/j.cellsig.2025.111910_bb0105","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1016\/j.cell.2021.04.011","article-title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome","volume":"184","author":"Huttlin","year":"2021","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.cellsig.2025.111910_bb0110","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1158\/2159-8290.CD-12-0093","article-title":"The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression","volume":"2","author":"Littlepage","year":"2012","journal-title":"Cancer Discov."},{"issue":"23","key":"10.1016\/j.cellsig.2025.111910_bb0115","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1038\/sj.onc.1210126","article-title":"Biochemical characterization of the zinc-finger protein 217 transcriptional repressor complex: identification of a ZNF217 consensus recognition sequence","volume":"26","author":"Cowger","year":"2007","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.cellsig.2025.111910_bb0120","doi-asserted-by":"crossref","first-page":"9703","DOI":"10.1074\/jbc.M611752200","article-title":"Identification of genes directly regulated by the oncogene ZNF217 using chromatin immunoprecipitation (ChIP)-chip assays","volume":"282","author":"Krig","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"51","key":"10.1016\/j.cellsig.2025.111910_bb0125","doi-asserted-by":"crossref","first-page":"84893","DOI":"10.18632\/oncotarget.12753","article-title":"Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress","volume":"7","author":"Jiang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2025.111910_bb0130","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.2147\/CMAR.S237726","article-title":"OIP5-AS1\/miR-137\/ZNF217 axis promotes malignant behaviors in epithelial ovarian cancer","volume":"12","author":"Guo","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111910_bb0135","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.gpb.2019.09.006","article-title":"hTFtarget: a comprehensive database for regulations of human transcription factors and their targets","volume":"18","author":"Zhang","year":"2020","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"16","key":"10.1016\/j.cellsig.2025.111910_bb0140","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1158\/0008-5472.CAN-13-0023","article-title":"TGF-\u03b2 modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment","volume":"73","author":"Yeung","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2025.111910_bb0145","first-page":"71","article-title":"Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells","volume":"2","author":"Bowen","year":"2009","journal-title":"BMC Med. Genet."},{"issue":"W1","key":"10.1016\/j.cellsig.2025.111910_bb0150","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111910_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/biom13121724","article-title":"Identification of a prognostic signature for ovarian cancer based on ubiquitin-related genes suggesting a potential role for FBXO9","volume":"13","author":"Luo","year":"2023","journal-title":"Biomolecules"},{"issue":"6220","key":"10.1016\/j.cellsig.2025.111910_bb0160","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cellsig.2025.111910_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr. Protoc. Bioinformatics"},{"issue":"18","key":"10.1016\/j.cellsig.2025.111910_bb0170","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021107735","article-title":"SCF(Fbxw5) targets kinesin-13 proteins to facilitate ciliogenesis","volume":"40","author":"Schweiggert","year":"2021","journal-title":"EMBO J."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111910_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23126806","article-title":"Breast cancer metastasis: mechanisms and therapeutic implications","volume":"23","author":"Park","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2025.111910_bb0180","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","article-title":"Epithelial mesenchymal transition in tumor metastasis","volume":"13","author":"Mittal","year":"2018","journal-title":"Annu. Rev. Pathol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111910_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020800","article-title":"The epithelial-mesenchymal transition at the crossroads between metabolism and tumor progression","volume":"23","author":"Fedele","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111910_bb0190","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","article-title":"EMT transition states during tumor progression and metastasis","volume":"29","author":"Pastushenko","year":"2019","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111910_bb0195","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20211754","article-title":"Epithelial-mesenchymal transition and its transcription factors","volume":"42","author":"Debnath","year":"2022","journal-title":"Biosci. Rep."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111910_bb0200","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1631\/jzus.B2100392","article-title":"Chemerin promotes proliferation and migration of ovarian cancer cells by upregulating expression of PD-L1","volume":"23","author":"Gao","year":"2022","journal-title":"J Zhejiang Univ Sci B"},{"issue":"11","key":"10.1016\/j.cellsig.2025.111910_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111806","article-title":"Primary ovarian carcinomas and abdominal metastasis contain 4,6-disulfated chondroitin sulfate rich regions, which provide adhesive properties to tumour cells","volume":"9","author":"Vallen","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111910_bb0210","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygyno.2008.11.032","article-title":"Multicellular spheroids in ovarian cancer metastases: biology and pathology","volume":"113","author":"Shield","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"32","key":"10.1016\/j.cellsig.2025.111910_bb0215","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1038\/s41388-021-01913-3","article-title":"ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers","volume":"40","author":"Li","year":"2021","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.cellsig.2025.111910_bb0220","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/10409238.2016.1178705","article-title":"Molecular insight into the regulation and function of MCAK","volume":"51","author":"Ritter","year":"2015","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"14","key":"10.1016\/j.cellsig.2025.111910_bb0225","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1158\/0008-5472.CAN-11-3095","article-title":"ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion","volume":"72","author":"Vendrell","year":"2012","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111910_bb0230","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.7314\/APJCP.2015.16.6.2459","article-title":"ZNF217 is overexpressed and enhances cell migration and invasion in colorectal carcinoma","volume":"16","author":"Zhang","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111910_bb0235","first-page":"3038","article-title":"ZNF217 is associated with poor prognosis and enhances proliferation and metastasis in ovarian cancer","volume":"7","author":"Li","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825003250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825003250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T22:36:18Z","timestamp":1756247778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825003250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":47,"alternative-id":["S0898656825003250"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111910","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor suppressor FBXO11 drives ubiquitin proteasomal degradation of KIF2C to limit ovarian cancer progression and is transcriptionally repressed by ZNF217","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111910"}}